Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118272153 | 11827215 | 3 | F | 20150525 | 20160902 | 20151211 | 20160909 | EXP | GB-MHRA-EYC 00130145 | GB-MYLANLABS-2015M1043287 | MYLAN | 0.00 | Y | 0.00000 | 20160909 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118272153 | 11827215 | 1 | PS | FINASTERIDE. | FINASTERIDE | 1 | Oral | 1 MG, QD | N | U | SEVERAL OVER A FEW YEARS | 77578 | 1 | MG | QD | ||||
118272153 | 11827215 | 2 | SS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG, QD | N | U | 0 | 1 | MG | QD | |||||
118272153 | 11827215 | 3 | C | MINOXIDIL. | MINOXIDIL | 1 | Topical | UNK | U | 0 | |||||||||
118272153 | 11827215 | 4 | C | ZOPICLONE | ZOPICLONE | 1 | 3.75 MG, UNK | U | 0 | 3.75 | MG | TABLET | |||||||
118272153 | 11827215 | 5 | C | PARACETAMOL | ACETAMINOPHEN | 1 | UNK | U | 0 | ||||||||||
118272153 | 11827215 | 6 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
118272153 | 11827215 | 7 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | UNK | U | 0 | ||||||||||
118272153 | 11827215 | 8 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 50 MG, QD | U | 0 | 50 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
118272153 | 11827215 | 1 | Androgenetic alopecia |
118272153 | 11827215 | 2 | Androgenetic alopecia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
118272153 | 11827215 | DE |
118272153 | 11827215 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118272153 | 11827215 | Anxiety | |
118272153 | 11827215 | Blood testosterone decreased | |
118272153 | 11827215 | Completed suicide | |
118272153 | 11827215 | Depression | |
118272153 | 11827215 | Headache | |
118272153 | 11827215 | Hypertension | |
118272153 | 11827215 | Insomnia | |
118272153 | 11827215 | Nausea | |
118272153 | 11827215 | Palpitations | |
118272153 | 11827215 | Panic attack | |
118272153 | 11827215 | Suicidal ideation | |
118272153 | 11827215 | Testicular pain | |
118272153 | 11827215 | Thinking abnormal | |
118272153 | 11827215 | Vomiting | |
118272153 | 11827215 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
118272153 | 11827215 | 1 | 200907 | 201107 | 0 | |
118272153 | 11827215 | 2 | 201404 | 20150720 | 0 | |
118272153 | 11827215 | 3 | 201505 | 0 | ||
118272153 | 11827215 | 4 | 20150821 | 0 | ||
118272153 | 11827215 | 7 | 20151003 | 0 | ||
118272153 | 11827215 | 8 | 20151030 | 0 |